During the past decade, Penn State Heart and Vascular Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Penn State Heart and Vascular Institute" are "Acute ST Elevation Myocardial Infarction" (1 trials) and "Atrial Fibrillation" (1 trials). Many other conditions were trialed in "Penn State Heart and Vascular Institute" in a lesser frequency.

Most popular intervention types in "Penn State Heart and Vascular Institute" are "Drug" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Cardiac CryoCor Cryoablation System" (1 trials), "Epoetin alfa" (1 trials) and "Medical management" (1 trials). Other intervention names were less common.

The vast majority of trials in "Penn State Heart and Vascular Institute" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Penn State Heart and Vascular Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Penn State Heart and Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Penn State Heart and Vascular Institute, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".